Publication | Closed Access

A randomized, double-blind controlled trial of interferon alpha-2b and ribavirin vs. interferon alpha-2b and amantadine for treatment of chronic hepatitis C non-responder to interferon monotherapy

HepatologyHepatitis CViral HepatitisImmunologyClinical TrialsHepatitisAntiviral TherapyTreatment OptionInterferon Alpha-2bPharmacotherapyAntiviral DrugMedicine